文献速递糖尿病

1型糖尿病残留C肽患者的白细胞介素-35水平升高

Increased Interleukin-35 Levels in Patients With Type 1 Diabetes With Remaining C-Peptide.
PubMed 文献 · Diabetes Care · 2017-06-15

在乌普萨拉大学医院招募113例病程≥10年的1型糖尿病患者,用超敏C肽ELISA判定残留β细胞功能并检测血浆白细胞介素-35(IL-35)。C肽阴性患者IL-35水平明显更低,伴IL-35+调节性T细胞、IL-35+调节性B细胞及IL-35产生性CD8+Foxp3+细胞比例同时下降;C肽阳性患者中Tregs、CD4+及CD8+ T细胞中IL-17a+细胞比例更低。

要点

  • 病程≥10年的1型糖尿病中,C肽阴性患者血IL-35浓度明显低于C肽阳性患者。
  • C肽阴性患者同时见IL-35+调节性T细胞、IL-35+调节性B细胞及IL-35产生性CD8+Foxp3+细胞比例下降。
  • C肽阳性患者Tregs、CD4+ T细胞及CD8+ T细胞中IL-17a+细胞比例更低。

核心结论

  • 病程超过10年仍有残留内源性β细胞功能的1型糖尿病患者与其他长病程1型糖尿病患者在免疫学上不同,尤其表现为IL-35产生明显更高。

研究设计与样本

  • 在乌普萨拉大学医院招募113例年龄≥18岁、病程≥10年的1型糖尿病患者,用超敏C肽ELISA判定残留β细胞功能,并检测血浆细胞因子包括IL-35。
  • 另从已识别的C肽阳性患者中取14例、C肽阴性患者中取12例,并取15名健康对照者,采集血样用于外周血单个核细胞的即时研究。

主要发现

  • C肽阴性患者血IL-35浓度明显更低,并伴有IL-35+调节性T细胞、IL-35+调节性B细胞及IL-35产生性CD8+Foxp3+细胞比例同时下降。
  • C肽阳性患者中Tregs、CD4+ T细胞及CD8+ T细胞中IL-17a+细胞比例更低。
  • 原文指出IL-35此前已被显示可维持Tregs表型、阻断T-helper 17细胞分化,从而减弱对β细胞的免疫攻击。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Many patients with long-standing type 1 diabetes have remaining functional β-cells. This study investigated immunological differences between patients with or without measurable remaining endogenous insulin production after ≥10 years duration of disease. RESEARCH DESIGN AND METHODS: Patients (n = 113; ≥18 years of age) with type 1 diabetes and with disease duration of ≥10 years were recruited at Uppsala University Hospital. Residual β-cell function was determined with an ultrasensitive C-peptide ELISA. Circulating cytokines, including interleukin-35 (IL-35), were determined in plasma. Additional blood samples were collected from 14 of the identified C-peptide-positive patients and 12 of the C-peptide-negative patients, as well as from 15 healthy control subjects, and were used for immediate investigation of peripheral blood mononuclear cells. RESULTS: The blood concentration of the cytokine IL-35 was markedly lower in C-peptide-negative patients, and this was associated with a simultaneous decrease in the proportion of IL-35+ regulatory T cells (Tregs), IL-35+ regulatory B cells, and IL-35-producing CD8+Foxp3+ cells. IL-35 has previously been shown to maintain the phenotype of Tregs, block the differentiation of T-helper 17 cells, and thereby dampen immune assaults to β-cells. We found that the proportions of IL-17a+ cells among the Tregs, CD4+ T cells, and CD8+ T cells were lower in the C-peptide-positive patients. CONCLUSIONS: Patients with remaining endogenous β-cell function after >10 years duration of type 1 diabetes differ immunologically from other patients with long-standing type 1 diabetes. In particular, they have a much higher IL-35 production.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Espes D, Singh K, Sandler S, et al. Increased Interleukin-35 Levels in Patients With Type 1 Diabetes With Remaining C-Peptide. Diabetes Care. 2017. PMID: 28620093. doi:10.2337/dc16-2121

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。